Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study.
Liqin GaoYanping SongXiaodong SunJunjun ZhangYuling LiuYouxin ChenZhifeng WuYe JianXiaoling LiuLin LvShaojun ChenYu-Sheng WangNan ChenXiao KeFeng ZhangPublished in: Acta ophthalmologica (2023)
Intravitreal injections of 0.5 mg conbercept provided improvement in visual and anatomical outcomes in pmCNV patients with low rates of ocular and nonocular safety events.